| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0378-5173(02)00075-3 |
| P698 | PubMed publication ID | 11996821 |
| P2093 | author name string | Yasuyuki Sadzuka | |
| Takashi Sonobe | |||
| Sadao Hirota | |||
| Akiko Nakade | |||
| Atsuo Miyagishima | |||
| Rieko Hirama | |||
| Yasuo Nozawa | |||
| P2860 | cites work | Risk factors for doxorubicin-induced congestive heart failure | Q28328220 |
| Highly specific inhibitory effect of three-component hybrid liposomes including sugar surfactants on the growth of glioma cells | Q31753126 | ||
| Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma | Q33498748 | ||
| Exchange of monooleoylphosphatidylcholine as monomer and micelle with membranes containing poly(ethylene glycol)-lipid | Q33907811 | ||
| Adriamycin. A new anticancer drug with significant clinical activity | Q34699440 | ||
| Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity | Q35334208 | ||
| Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy | Q37650345 | ||
| The influence of physical characteristics of liposomes containing doxorubicin on their pharmacological behavior | Q44605748 | ||
| Comparative pharmacokinetic study of adriamycin and 4'epi-adriamycin after their simultaneous intravenous administration. | Q54150263 | ||
| Antitumor effect of liposome-entrapped adriamycin administered via the portal vein. | Q54985807 | ||
| Diffusion of univalent ions across the lamellae of swollen phospholipids | Q59447717 | ||
| Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin | Q69173245 | ||
| Determination of adriamycin (doxorubicin) and related fluorescent compounds in rat lymph and gall by high-performance liquid chromatography | Q70875864 | ||
| Determination of the thickness of the fixed aqueous layer around polyethyleneglycol-coated liposomes | Q71567040 | ||
| Analysis of adriamycin and adriamycinol in micro volumes of rat plasma | Q71688364 | ||
| The Effect of Dose on the Distribution of Adriamycin Encapsulated in Polyethyleneglycol-Coated Liposomes | Q72012018 | ||
| Effects of administered route on tissue distribution and antitumor activity of polyethyleneglycol-coated liposomes containing adriamycin | Q73043551 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | doxorubicin | Q18936 |
| P304 | page(s) | 171-180 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | International Journal of Pharmaceutics | Q6051539 |
| P1476 | title | Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome | |
| P478 | volume | 238 |
| Q36953748 | A light-controlled switch after dual targeting of proliferating tumor cells via the membrane receptor EGFR and the nuclear protein Ki-67 |
| Q53133237 | A lyophilized sterically stabilized liposome-containing docetaxel: in vitro and in vivo evaluation. |
| Q35624235 | Accelerated blood clearance phenomenon upon cross-administration of PEGylated nanocarriers in beagle dogs |
| Q44834368 | Amphoteric hyaluronic acid derivative for targeting gene delivery |
| Q38090650 | Anthracyclines as effective anticancer drugs |
| Q38564219 | Anti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculature. |
| Q33320876 | Antineovascular therapy with angiogenic vessel-targeted polyethyleneglycol-shielded liposomal DPP-CNDAC. |
| Q48718420 | Contribution of Kupffer cells to liposome accumulation in the liver |
| Q34629506 | Creation of lung-targeted dexamethasone immunoliposome and its therapeutic effect on bleomycin-induced lung injury in rats |
| Q89910156 | Current developments in drug delivery with thermosensitive liposomes |
| Q38868069 | Effects of PEGylated paclitaxel nanocrystals on breast cancer and its lung metastasis |
| Q90062283 | Hybrid Clustered Nanoparticles for Chemo-Antibacterial Combinatorial Cancer Therapy |
| Q37841616 | In vitro and in vivo characterizations of PEGylated liposomal doxorubicin |
| Q33996594 | In vitro and in vivo evaluation of folate receptor-targeting amphiphilic copolymer-modified liposomes loaded with docetaxel |
| Q61803080 | Influence of PEG coating on the biodistribution and tumor accumulation of pH-sensitive liposomes |
| Q37792340 | Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects |
| Q47324858 | Investigation on design of stable etoposide-loaded PEG-PCL micelles: effect of molecular weight of PEG-PCL diblock copolymer on the in vitro and in vivo performance of micelles |
| Q92761164 | Liposome mimicking polymersomes; A comparative study of the merits of polymersomes in terms of formulation and stability |
| Q36883923 | Nanoemulsion loaded with lycobetaine-oleic acid ionic complex: physicochemical characteristics, in vitro, in vivo evaluation, and antitumor activity |
| Q39577084 | Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery |
| Q39782641 | PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation |
| Q39958885 | PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer |
| Q35563280 | Pharmacokinetics of intraperitoneal cisplatin and doxorubicin. |
| Q38047267 | Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking |
| Q55208940 | RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells. |
| Q73837227 | Study on the characterization of mixed polyethyleneglycol modified liposomes containing doxorubicin |
| Q64063888 | Surface Modification of Liposomes by a Lipopolymer Targeting Prostate Specific Membrane Antigen for Theranostic Delivery in Prostate Cancer |
| Q37415968 | Surface engineering of liposomes for stealth behavior |
| Q36988355 | Surface-active liposomes for targeted cancer therapy |
| Q46762434 | The effect of the Pheroid delivery system on the in vitro metabolism and in vivo pharmacokinetics of artemisone |
Search more.